Literature DB >> 35284523

Is FOLFOX-HAIC superior to transarterial chemoembolization in treating large hepatocellular carcinoma?

Yun-Shi Cai1, Hong Wu1.   

Abstract

Entities:  

Year:  2022        PMID： 35284523      PMCID： PMC8847866          DOI： 10.21037/hbsn-21-503

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  6 in total

1.  Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.

Authors:  Nicolas Poté; François Cauchy; Miguel Albuquerque; Hélène Voitot; Jacques Belghiti; Laurent Castera; Hervé Puy; Pierre Bedossa; Valérie Paradis
Journal:  J Hepatol       Date:  2014-11-11       Impact factor: 25.083

2.  Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin Versus Transarterial Chemoembolization for Large Hepatocellular Carcinoma: A Randomized Phase III Trial.

Authors:  Qi-Jiong Li; Min-Ke He; Huan-Wei Chen; Wan-Qiang Fang; Yuan-Min Zhou; Li Xu; Wei Wei; Yao-Jun Zhang; Ying Guo; Rong-Ping Guo; Min-Shan Chen; Ming Shi
Journal:  J Clin Oncol       Date:  2021-10-14       Impact factor: 50.717

3.  Clinical usefulness of double biomarkers AFP and PIVKA-II for subdividing prognostic groups in locally advanced hepatocellular carcinoma.

Authors:  Hana Park; Seung Up Kim; Jun Young Park; Do Young Kim; Sang Hoon Ahn; Chae Yoon Chon; Kwang-Hyub Han; Jinsil Seong
Journal:  Liver Int       Date:  2013-07-29       Impact factor: 5.828

4.  Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).

Authors:  Jian Zhou; Huichuan Sun; Zheng Wang; Wenming Cong; Jianhua Wang; Mengsu Zeng; Weiping Zhou; Ping Bie; Lianxin Liu; Tianfu Wen; Guohong Han; Maoqiang Wang; Ruibao Liu; Ligong Lu; Zhengang Ren; Minshan Chen; Zhaochong Zeng; Ping Liang; Changhong Liang; Min Chen; Fuhua Yan; Wenping Wang; Yuan Ji; Jingping Yun; Dingfang Cai; Yongjun Chen; Wenwu Cheng; Shuqun Cheng; Chaoliu Dai; Wenzhi Guo; Baojin Hua; Xiaowu Huang; Weidong Jia; Yaming Li; Yexiong Li; Jun Liang; Tianshu Liu; Guoyue Lv; Yilei Mao; Tao Peng; Weixin Ren; Hongcheng Shi; Guoming Shi; Kaishan Tao; Wentao Wang; Xiaoying Wang; Zhiming Wang; Bangde Xiang; Baocai Xing; Jianming Xu; Jiamei Yang; Jianyong Yang; Yefa Yang; Yunke Yang; Shenglong Ye; Zhengyu Yin; Bixiang Zhang; Boheng Zhang; Leida Zhang; Shuijun Zhang; Ti Zhang; Yongfu Zhao; Honggang Zheng; Jiye Zhu; Kangshun Zhu; Rong Liu; Yinghong Shi; Yongsheng Xiao; Zhi Dai; Gaojun Teng; Jianqiang Cai; Weilin Wang; Xiujun Cai; Qiang Li; Feng Shen; Shukui Qin; Jiahong Dong; Jia Fan
Journal:  Liver Cancer       Date:  2020-11-11       Impact factor: 11.740

5.  Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors:  Maigeng Zhou; Haidong Wang; Xinying Zeng; Peng Yin; Jun Zhu; Wanqing Chen; Xiaohong Li; Lijun Wang; Limin Wang; Yunning Liu; Jiangmei Liu; Mei Zhang; Jinlei Qi; Shicheng Yu; Ashkan Afshin; Emmanuela Gakidou; Scott Glenn; Varsha Sarah Krish; Molly Katherine Miller-Petrie; W Cliff Mountjoy-Venning; Erin C Mullany; Sofia Boston Redford; Hongyan Liu; Mohsen Naghavi; Simon I Hay; Linhong Wang; Christopher J L Murray; Xiaofeng Liang
Journal:  Lancet       Date:  2019-06-24       Impact factor: 79.321

6.  Cancer incidence and mortality in China, 2014.

Authors:  Wanqing Chen; Kexin Sun; Rongshou Zheng; Hongmei Zeng; Siwei Zhang; Changfa Xia; Zhixun Yang; He Li; Xiaonong Zou; Jie He
Journal:  Chin J Cancer Res       Date:  2018-02       Impact factor: 5.087
  6 in total
  1 in total

1.  Comparative effectiveness of interventional therapeutic modalities for unresectable hepatocellular carcinoma: A systematic review and network meta-analysis.

Authors:  Xin-Long Chen; Hai-Chuan Yu; Qi-Gang Fan; Qi Yuan; Wen-Kai Jiang; Shao-Zhen Rui; Wen-Ce Zhou
Journal:  Oncol Lett       Date:  2022-08-31       Impact factor: 3.111
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.